Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 19/20 | 0.71 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | LOXL3 | P58215 | 2/20 | 0.51 |
| ▸ | LOX | P28300 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19259918 | 0.83 | LOXL2 (1.00) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL28652340 | 0.81 | LOXL2 (0.69) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL19259647 | 0.80 | LOXL2 (0.74) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL28663671 | 0.78 | LOXL2 (0.75) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL29971590 | 0.77 | LOXL2 (0.68) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL28927244 | 0.73 | LOXL2 (0.71) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL13942073 | 0.71 | LOXL2 (0.51) | LOXL2KCNH2 | |
| SCHEMBL17794793 | 0.69 | LOXL2 (0.47) | LOXL2KCNH2 | |
| SCHEMBL19274645 | 0.69 | LOXL2 (1.00) | LOXL2AOC3KCNH2MAOALOXL3 | |
| SCHEMBL28638918 | 0.68 | LOX (0.69) | LOXL2AOC3KCNH2MAOALOXL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311839-B | Methylamine derivatives as lysyl oxidase inhibitors for the treatment of cancer | 癌症研究协会皇家癌症医院 | 2021-11-02 | — | — | CN | disclosed |